The Artificial Intelligence in Medical Imaging segmentation by application distinguishes four primary use‑cases that collectively drive market revenue. Diagnostic imaging—encompassing radiography, CT, MRI, and ultrasound interpretation—accounts for roughly 45% of total spend, reflecting its entrenched role in hospital workflows and the high volume of examinations processed daily. Screening applications, such as AI‑enhanced mammography and lung cancer detection, contribute about 25%; they benefit from preventive‑care incentives and population‑level screening programs that demand scalable, high‑throughput solutions. Treatment planning—including AI‑assisted radiotherapy contouring and surgical navigation—represents 20% of the market, where precision directly influences procedural outcomes and reimbursement rates. Finally, research & development activities, covering algorithm validation, clinical trials, and exploratory use‑cases, occupy the remaining 10%, supporting innovation pipelines and early‑adopter adoption. Each segment’s revenue share aligns with its clinical impact, reimbursement landscape, and technology maturity, forming the quantitative backbone of the overall market size.